When to give up car is a difficult decision to make
Jan-28-2007
Cleo Johnson knew the time had come to give up her car. Johnson, 80, who lives in Carson City, found that her glaucoma made it hard to see while driving.
When to give up driving is a difficult decision
Jan-28-2007
CLEO JOHNSON KNEW the time had come to give up her car. Johnson, 80, who lives in Carson City, found that her glaucoma made it hard to see while driving.
Retiring the keys a difficult decision
Jan-28-2007
Cleo Johnson knew the time had come to give up her car. Johnson, 80, who lives in Carson City, found that her glaucoma made it hard to see while driving.
Monocular treatment trial for glaucoma might not be valid
Jan-26-2007
Should clinicians abandon the use of a monocular drug trial in patients with glaucoma, which has been the preferred practice pattern for primary open-angle glaucoma issued by the American Academy of ...
ECP with phacoemulsification can be beneficial in those with cataract, concurrent glaucoma
Jan-26-2007
In a controlled trial, endocyclophotocoagulation combined with phacoemulsification showed significant benefits in treating cataract patients who also have glaucoma, according to Stanley J. Berke, MD.
Dr. James Tsai oversees department at Yale
Jan-26-2007
Glaucoma specialist James C. Tsai, MD, MBA, has been named chairman of the Yale School of Medicine's Department of Ophthalmology and Visual Science.
Glaucoma: Save Your Sight - Glaucoma Screening
Jan-17-2007
Title: Glaucoma: Save Your Sight - Glaucoma Screening
Category: Doctor's Views
Created: 2/3/2005
Last Editorial Review: 1/18/2007
Category: Doctor's Views
Created: 2/3/2005
Last Editorial Review: 1/18/2007
FDA Approves Device for the Diagnosis and Management of Glaucoma in LASIK Patients
Jan-20-2007
RetinaPharma announces FDA-clearance of TonoPach device for glaucoma determination: new technology especially important for diagnosis and management of glaucoma in LASIK patients RetinaPharma, a privately-held portfolio company of the Hopkins Capital Group, LLC, announced today that it has received 510(k) FDA clearance to market its...
Glaucoma awareness urged during January
Jan-17-2007
WAHIAWA - With symptoms that develop slowly over time, over a million Americans are unaware they are living with, or at risk of developing, glaucoma.
Akorn Enters Ophthalmic ANDA Drug Pact
Jan-10-2007
Akorn, Inc. has signed a definitive agreement with Azad Pharma to develop and supply Latanoprost, Bimatoprost and Travoprost, three ophthalmic ANDA drug products for the treatment of glaucoma.
Free eye exams available for Glaucoma Awareness Month
Jan-03-2007
If you have glaucoma, this is all you will see. Photo Courtesy of National Eye Institute/National Institutes of Health - From release SAN FRANCISCO - Each year as the New Year approaches, people around the ...